Company: HUM
Filing Date: 2025-03-28
Form Type: 424B5
Source: 0001628280-25-015313
Chunk: 6

Company: HUMANA INC
Filing Date: 2025-03-28
Form: 424B5
Chunk 6
---
 business, primarily our T-2017 East Region contract, as well as the operations of our PBM business. The CenterWell segment includes our pharmacy, primary care, and home solutions operations. The segment also includes our strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as our minority ownership interest in hospice operations. Services offered by this segment are designed to enhance the overall healthcare experience. These services may lead to lower utilization associated with improved member health and/or lower drug costs.

#### Corporate Information
Our principal executive offices are located at 500 West Main Street, Louisville, Kentucky 40202, and our telephone number is (502) 580-1000.

<div align='center'>S-1</div>

Table of Content s

THE OFFERING The following summary contains basic information about the notes and is not intended to be complete. For a more complete understanding of the notes, please refer to the section entitled “Description of the Notes” in this prospectus supplement and “Description of the Debt Securities” in the accompanying prospectus.

| Issuer                 |     | Humana Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| Notes Offered          |     | $250 million initial aggregate principal amount of 5.375% Senior Notes due 2031 (referred to as the additional 2031 notes). The additional 2031 notes offered hereby will be an additional issuance of the 5.375% Senior Notes due 2031 that we issued in an aggregate principal amount of $1,250 million on March 13, 2024 (referred to as the existing 2031 notes), will be fungible with the existing 2031 notes and will be consolidated with and form a single series with the existing 2031 notes. The additional 2031 notes offered hereby will have terms that are identical to the terms of the existing 2031 notes (except for the issuance date and the issuance price) and will have the same ISIN and CUSIP numbers as the existing 2031 notes.                                                                     
 We refer to the additional 2031 notes and, where the context requires, together with the existing 2031 notes, as the notes. Immediately after giving effect to the issuance of the additional 2031 notes offered hereby and, together with the previously issued $1,250 million in aggregate principal amount of the existing 2031 notes, the outstanding principal amount of the notes will be $1,500 million.